专利检索 ap:("Denali Therapeutics Inc.") AND inv:"Federica Tonelli" 第 1 页

1.

发明授权
Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1) 有权

公开(公告)号：US10709692B2

公开(公告)日：2020-07-14

申请号：US15780620

申请日：2016-12-02

申请人： Denali Therapeutics Inc.

发明人： Giorgio Bonanomi , Anthony A. Estrada , Jianwen A. Feng , Brian Fox , Colin Philip Leslie , Joseph P. Lyssikatos , Carmela Napolitano , Alfonso Pozzan , Anantha Sudhakar , Zachary K. Sweeney , Federica Tonelli , Javier de Vicente Fidalgo

IPC分类号： A61K31/422 , C07D413/04 , C07D261/02 , A61P1/00 , A61P29/00 , A61K31/4439

摘要： The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

2.

发明申请
ISOXAZOLIDINE DERIVED INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE 1 (RIPK1) 审中-公开

公开(公告)号：US20180353480A1

公开(公告)日：2018-12-13

申请号：US15780620

申请日：2016-12-02

申请人： Denali Therapeutics Inc.

发明人： Giorgio Bonanomi , Anthony A. Estrada , Jianwen A. Feng , Brian Fox , Colin Philip Leslie , Joseph P. Lyssikatos , Carmela Napolitano , Alfonso Pozzan , Anantha Sudhakar , Zachary K. Sweeney , Federica Tonelli , Javier de Vicente Fidalgo

IPC分类号： A61K31/422 , A61K31/4439 , A61P1/00 , A61P29/00

CPC分类号： A61K31/422 , A61K31/4439 , A61K2121/00 , A61P1/00 , A61P29/00 , C07D261/02 , C07D413/04

摘要： The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.